Wasatch Advisors Has Cut Its Chemocentryx (CCXI) Holding by $659,310 as Shares Rose; Fuller H B Co (FUL) Valuation Rose While Beaconlight Capital Trimmed Holding by $614,670

ChemoCentryx, Inc. (NASDAQ:CCXI) Logo

Wasatch Advisors Inc decreased its stake in Chemocentryx Inc (CCXI) by 2.76% based on its latest 2018Q4 regulatory filing with the SEC. Wasatch Advisors Inc sold 65,931 shares as the company’s stock rose 6.99% with the market. The institutional investor held 2.32M shares of the health care company at the end of 2018Q4, valued at $25.35 million, down from 2.39 million at the end of the previous reported quarter. Wasatch Advisors Inc who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $759.67 million market cap company. The stock increased 3.62% or $0.46 during the last trading session, reaching $13.16. About 210,696 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since April 25, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 09/05/2018 – CHEMOCENTRYX INC – EXPECTS TO UTILIZE CASH AND INVESTMENTS BETWEEN $65 MLN AND $75 MLN FOR TWELVE MONTHS ENDING DECEMBER 31, 2018; 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 09/03/2018 ChemoCentryx 4Q EPS 80c; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS); 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M

Beaconlight Capital Llc decreased its stake in Fuller H B Co (FUL) by 9.56% based on its latest 2018Q4 regulatory filing with the SEC. Beaconlight Capital Llc sold 14,635 shares as the company’s stock rose 9.09% with the market. The hedge fund held 138,455 shares of the home furnishings company at the end of 2018Q4, valued at $5.91M, down from 153,090 at the end of the previous reported quarter. Beaconlight Capital Llc who had been investing in Fuller H B Co for a number of months, seems to be less bullish one the $2.44 billion market cap company. The stock decreased 3.88% or $1.94 during the last trading session, reaching $48.01. About 119,858 shares traded. H.B. Fuller Company (NYSE:FUL) has risen 3.56% since April 25, 2018 and is uptrending. It has underperformed by 0.81% the S&P500. Some Historical FUL News: 28/03/2018 – HB FULLER CO – CONFIRM FISCAL YEAR 2018 ADJUSTED DILUTED EPS GUIDANCE $3.10 TO $3.40; 22/03/2018 – Global Adhesives and Sealants Market 2018: Industry Analysis & Outlook 2022 Featuring 3M, Henkel, Arkema and H.B. Fuller – ResearchAndMarkets.com; 28/03/2018 – HB Fuller 1Q Rev $713.1M; 12/04/2018 – HB FULLER CO FUL.N SETS REGULAR QUARTERLY DIVIDEND OF $0.155/SHR; 12/04/2018 – H.B. FULLER BOOSTS QTRLY DIV; 28/03/2018 – HB FULLER CO – STILL EXPECT TO INVEST APPROXIMATELY $90 MLN IN CAPITAL ITEMS IN 2018; 04/05/2018 – Victory Capital Management Inc. Exits Position in HB Fuller; 28/03/2018 – HB Fuller 1Q Net $47.7M; 28/03/2018 – HB Fuller 1Q EPS 92c; 24/04/2018 – Channing Capital Buys New 2.1% Position in HB Fuller

Wasatch Advisors Inc, which manages about $19.28 billion and $7.50 billion US Long portfolio, upped its stake in Mercadolibre Inc (NASDAQ:MELI) by 25,594 shares to 136,894 shares, valued at $40.09M in 2018Q4, according to the filing. It also increased its holding in Texas Capital Bancshares Inc (NASDAQ:TCBI) by 10,416 shares in the quarter, for a total of 908,302 shares, and has risen its stake in Investar Hldg Corp (NASDAQ:ISTR).

Since October 26, 2018, it had 0 buys, and 6 selling transactions for $1.47 million activity. 7,211 shares were sold by Schall Thomas J., worth $86,554. 6,172 shares valued at $74,079 were sold by Cappel Markus J. on Thursday, January 10.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Globenewswire.com which released: “ChemoCentryx to Present at Two Upcoming Investor Conferences – GlobeNewswire” on May 30, 2018, also Benzinga.com with their article: “10 Biggest Price Target Changes For Wednesday – Benzinga” published on March 27, 2019, Seekingalpha.com published: “ChemoCentryx Looks Like An Attractive Investment – Seeking Alpha” on November 22, 2017. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Benzinga.com and their article: “10 Stocks To Watch For September 27, 2018 – Benzinga” published on September 27, 2018 as well as Seekingalpha.com‘s news article titled: “ChemoCentryx launches $75M stock offering – Seeking Alpha” with publication date: September 26, 2018.

Investors sentiment decreased to 0.93 in Q4 2018. Its down 0.05, from 0.98 in 2018Q3. It is negative, as 7 investors sold CCXI shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. Moreover, Carmignac Gestion has 0.2% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 1.22M shares. Tower Rech Capital Limited Liability (Trc) invested in 0% or 257 shares. Alliancebernstein Ltd Partnership holds 46,700 shares. Acadian Asset Mgmt Ltd Liability Co holds 818,489 shares or 0.04% of its portfolio. Aqr Cap Management Ltd Company holds 22,364 shares. Renaissance Technologies Ltd Liability Company stated it has 883,381 shares or 0.01% of all its holdings. Dimensional Fund Limited Partnership reported 632,061 shares. Vanguard Grp Inc Inc reported 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Amer Group Inc reported 14,790 shares. 17,971 are held by Sg Americas Securities Ltd Com. Trexquant Ltd Partnership holds 33,717 shares. Qs Invsts Limited holds 0% or 643 shares. American Century reported 0% stake. Fmr Lc has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 644,305 shares. 38,600 are held by Adams Diversified Equity Fund Inc.

Beaconlight Capital Llc, which manages about $170.27M and $289.01 million US Long portfolio, upped its stake in Builders Firstsource Inc (NASDAQ:BLDR) by 327,533 shares to 2.69 million shares, valued at $29.33 million in 2018Q4, according to the filing. It also increased its holding in Stars Group Inc by 1.21 million shares in the quarter, for a total of 3.27M shares, and has risen its stake in Golar Lng Ltd Bermuda (NASDAQ:GLNG).

More notable recent H.B. Fuller Company (NYSE:FUL) news were published by: Globenewswire.com which released: “HB Fuller Announces Quarterly Dividend NYSE:FUL – GlobeNewswire” on October 04, 2018, also Benzinga.com with their article: “Earnings Scheduled For March 27, 2019 – Benzinga” published on March 27, 2019, Prnewswire.com published: “HB Fuller Unveils the Next Generation of Adhesive Solutions for Woodworking at Ligna 2019 – PRNewswire” on April 10, 2019. More interesting news about H.B. Fuller Company (NYSE:FUL) were released by: Prnewswire.com and their article: “HB Fuller Reports First Quarter 2019 Results – PRNewswire” published on March 27, 2019 as well as Seekingalpha.com‘s news article titled: “H.B. Fuller Q4 2019 Earnings Preview – Seeking Alpha” with publication date: March 26, 2019.

ChemoCentryx, Inc. (NASDAQ:CCXI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *